Literature DB >> 26619773

Cognition and Plasma Ratio of Clozapine to N-desmethylclozapine in Patients With Clozapine-Resistant Schizophrenia.

Allen E Thornton1, Ric M Procyshyn1, Alasdair M Barr1, G William MacEwan1, William G Honer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26619773     DOI： 10.1176/appi.ajp.2015.15070899

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

1.  Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.

Authors:  Jessica W Y Yuen; David D Kim; Ric M Procyshyn; Randall F White; William G Honer; Alasdair M Barr
Journal:  Front Neurosci       Date:  2018-04-04       Impact factor: 4.677

2.  Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.

Authors:  Lik Hang N Lee; Ric M Procyshyn; Randall F White; Todd S Woodward; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

3.  Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.

Authors:  Kenya A Costa-Dookhan; Tarek K Rajji; Veronica N Tran; Sylvie Bowden; Daniel J Mueller; Gary J Remington; Sri Mahavir Agarwal; Margaret K Hahn
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.